Green S, Buchbinder R, Glazier R, Forbes A
Monash University, Australasian Cochrane Centre, Monash Medical Centre, Locked Bag 29, Clayton, Victoria, Australia, 3168.
Cochrane Database Syst Rev. 2007 Jul 18;2006(4):CD001156. doi: 10.1002/14651858.CD001156.pub2.
Shoulder pain is a common problem and although there are many accepted standard forms of conservative therapy for shoulder disorders including non-steroidal anti-inflammatory drugs, glucocorticosteroid injections, oral glucocorticosteroid medication, manipulation under anaesthesia, physical therapy, hydrodilatation (distension arthrography) and surgery, evidence of their efficacy is not well established.
To review the efficacy of common interventions for shoulder pain.
We searched the Cochrane Musculoskeletal Group trials register, Cochrane Controlled Trials Register, MEDLINE, EMBASE, CINAHL, and Science Citation Index) up to May 1998, and hand searched major textbooks, bibliographies of relevant literature, the fugitive literature, and the subject indices of relevant journals including: American College of Rheumatology;British College of Rheumatologists; the Biennial Conference of the Manipulative Physiotherapy Association of Australia;International Federation of Manual Therapists conference proceedings; British Orthopaedic Association;and American Orthopaedic Association.
Each identified study was assessed for possible inclusion by two independent reviewers based on the blinded methods sections. The determinants for inclusion were that the trial include an intervention of interest (non-steroidal anti-inflammatory drugs, intra-articular or subacromial glucocorticosteroid injection, oral glucocorticosteroid treatment, physiotherapy, manipulation under anaesthesia, hydrodilatation, or surgery); that treatment allocation was randomized; and that the outcome assessment was blinded.
Methodological quality was assessed by two independent, blinded reviewers. Data relating to selection criteria, outcome measurement and treatment effect was extracted from the blinded trials. Range of motion scores were entered as degrees of restriction to movement, and all pain and overall effect scores were transformed to 100 point scales. For continuous outcome measures, where standard deviation was not reported it was either calculated from the raw data or converted from standard error of the mean. If neither of these were reported, authors were contacted in an effort to obtain the missing values. Effect sizes were calculated and combined in a pooled analysis if study population, endpoint and intervention were comparable.
Thirty one trials met inclusion criteria. Mean methodological quality score was 16.8 (9.5 - 22) out of possible score of 40. Selection criteria varied widely even for the same diagnostic label. There was no uniformity in outcome measures used and their measurement properties were rarely reported. Effect sizes for individual trials were small (-1.4 to 3.0). The results of only three studies investigating "rotator cuff tendonitis" could be pooled. Benefit of subacromial steroid injection over placebo for improving range of abduction (weighted difference between means (WMD) 35 degrees , 95% CI 14 to 55) was the only positive finding.
AUTHORS' CONCLUSIONS: There is little evidence to support or refute the efficacy of common interventions for shoulder pain. As well as, the need for further well designed clinical trials, more research is needed to establish a uniform method of defining shoulder disorders and developing outcome measures which are valid, reliable and responsive in these study populations.
肩部疼痛是一个常见问题,尽管对于肩部疾病存在许多公认的保守治疗标准方法,包括非甾体类抗炎药、糖皮质激素注射、口服糖皮质激素药物、麻醉下手法治疗、物理治疗、水扩张术(关节造影扩张)和手术,但其疗效证据并不充分。
综述肩部疼痛常见干预措施的疗效。
我们检索了Cochrane肌肉骨骼组试验注册库、Cochrane对照试验注册库、MEDLINE、EMBASE、CINAHL和科学引文索引,截至1998年5月,并手工检索了主要教科书、相关文献的参考文献、灰色文献以及相关期刊的主题索引,包括:美国风湿病学会;英国风湿病学家学会;澳大利亚手法物理治疗协会双年会议;国际手法治疗师联合会会议论文集;英国骨科协会;以及美国骨科协会。
两名独立评审员根据盲法方法部分对每项识别出的研究进行可能入选的评估。入选的决定因素是试验包括感兴趣的干预措施(非甾体类抗炎药、关节内或肩峰下糖皮质激素注射、口服糖皮质激素治疗、物理治疗麻醉下手法治疗、水扩张术或手术);治疗分配是随机的;并且结局评估是盲法的。
两名独立的盲法评审员评估方法学质量。从盲法试验中提取与入选标准、结局测量和治疗效果相关的数据。活动范围评分以运动受限程度输入,所有疼痛和总体效果评分转换为100分制。对于连续结局测量,如果未报告标准差,则从原始数据计算或从均值标准误差转换。如果这两者都未报告,则联系作者以获取缺失值。如果研究人群、终点和干预措施具有可比性,则计算效应量并在汇总分析中合并。
31项试验符合入选标准。在可能的40分中,平均方法学质量评分为16.8(9.5 - 22)。即使对于相同的诊断标签,入选标准也差异很大。所使用的结局测量方法没有一致性,并且很少报告其测量特性。个别试验的效应量较小(-1.4至3.0)。仅能汇总三项调查“肩袖肌腱炎”的研究结果。肩峰下类固醇注射优于安慰剂改善外展范围(均值加权差异(WMD)35度,95%CI 14至55)是唯一的阳性发现。
几乎没有证据支持或反驳肩部疼痛常见干预措施的疗效。除了需要进一步设计良好的临床试验外,还需要更多研究来建立一种统一的方法来定义肩部疾病,并开发在这些研究人群中有效、可靠且有反应的结局测量方法。